Joyvié Health Raises $1.04M to Redesign Continence Care After Personal Loss

Jan de Vries · 2026-06-05

UK-based Joyvié Health has closed its pre-Seed funding round, raising a total of $1.04 million for its continence underwear. This product was designed from first principles to significantly reduce stool-to-skin contact, maintain skin integrity, and ease the burden on caregivers. The funding includes an Innovate UK grant, plus investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and individual angel investors. "Products designed for care should never cause harm. That's not a vision statement. It's the reason this company exists," says Zoe Robson, Founder & CEO of Joyvié Health. ### A Wave of HealthTech Funding in 2026 Joyvié Health's pre-Seed round is part of a bigger picture. Across the UK and Europe, several HealthTech companies in adjacent areas—care delivery, clinical workflow, elderly care, medical devices, and women's health—have raised significant capital this year. In the UK: - Semble raised $36.2 million to scale its healthcare management platform for outpatient providers. - Evaro secured $21.9 million to expand NHS-licensed embedded health services. - JAAQ closed $15.6 million to grow enterprise partnerships. - Calibre emerged from stealth with $2.9 million to tackle health "guesswork." - Nul raised $875,000 to launch and expand its alcohol-dependence care platform. Across Europe: - Recare in Berlin raised up to $38.6 million to scale its AI platform for hospitals and care providers. - Patronus raised $11.5 million for a senior-friendly emergency smartwatch and family app. - Tucuvi raised $17.7 million to scale voice-AI nursing follow-up automation. - Ditto in Rotterdam raised $7.9 million to make medical information easier for patients to understand. - ShanX Medtech secured $25 million to advance antimicrobial-resistance diagnostics, starting with women's health in urinary tract infections. - MedVasc raised $2.3 million to progress its anesthesia catheter toward US approval. Taken together, these rounds add up to over $180 million in related 2026 HealthTech funding. "At Lavender Ventures, we are committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people's lives. We believe the market is ripe for innovation, and Joyvie's approach has the potential to deliver significant benefits not only for individuals, but also for carers, healthcare systems and the environment," adds Gail Armstrong of Lavender Ventures.  ### A Personal Story That Sparked a Mission Joyvié Health was founded by Zoe Robson after the death of her father, Fred, in 2025. Fred was 77, fit, and sharp-minded when a late-stage pancreatic cancer diagnosis arrived without warning on Christmas Eve 2024. Eleven weeks later, he was gone. In those eleven weeks, Fred lost bowel control and had to wear a diaper. Feces trapped against skin breaks it down—moisture, pathogens, and pH imbalance cause damage that never fully heals. His skin broke down. His dignity went with it, change by change. And Ruth, his wife and primary caregiver, carried a burden that was invisible to the world outside and impossibly hard to bear. "My parents didn't deserve that," says Zoe. "They were both at their most vulnerable—and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mom. It wasn't from lack of care. It's a design failure." ### Redesigning Continence Care from the Ground Up The company is on a mission to end the silent humiliation of fecal incontinence (FI)—a condition affecting an estimated 656 million people globally. Yet the most common non-invasive solution remains unchanged for decades: diapers and pads. Where existing non-invasive products trap feces against the skin, Joyvié contains stool in a disposable pouch immediately after excretion. This significantly reduces skin contact, preserves dignity, and cuts the time and burden of care. Early testing shows approximately 90% reduction in stool-to-skin contact and about 70% faster changes. Fecal incontinence is often caused by conditions like diarrhea, constipation, nerve damage, or muscle weakness. For millions of people—including the elderly, those with chronic illnesses, and new mothers—it's a daily reality that current products fail to address properly. Joyvié's innovation could change that, offering a solution that works for both patients and caregivers.